| Net Cash Provided by (Used in) Operating Activities |
$1,859,544 |
USD |
22% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$276,253 |
USD |
-99% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,219,315 |
USD |
69% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$519,999 |
USD |
-101% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$32,371,386 |
USD |
-25% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$44,489,087 |
USD |
119% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$44,782,289 |
USD |
121% |
Q4 2024 |
FY 2024 |
| Depreciation |
$582,604 |
USD |
1035% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$7,606,027 |
USD |
204% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$195,973 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$100,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$13,005,867 |
USD |
17% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
$226,722,424 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |